XML 28 R19.htm IDEA: XBRL DOCUMENT v3.22.1
Revenue (Tables)
3 Months Ended
Mar. 31, 2022
Revenue  
Summary of the reductions to R&D costs related to reimbursement payments

Three Months Ended

March 31, 

(In thousands)

    

2022

    

2021

Viatris

$

1,536

$

94

Janssen

1,332

Total reduction to R&D expense, net

$

1,536

$

1,426